RICOVR’s patented testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non- invasive specimen collection and analytics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new testing diagnostics including COVID-19, additional drug panels, and critical disease testing.

RICOVR is driven by the belief that a more accurate and cost-effective solution should be  available for employers, law enforcement, healthcare systems and others relying on fast and reliable access to data.

RICOVR team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research to deliver on your needs today and tomorrow.

Management Team

Dr. Himanshu Bhatia Founder & CEO

  • 20+ years experience in Research, Development, and Commercialization of medical devices.
  • MD, MS (Biochemistry), and MBA.

Piyush Sadana Co-Founder & COO

  • Serial entrepreneur with 20+ years of experience in Investment Banking
    & Hi-Tech.
  • MBA, Columbia Business School.

Kyle Muse CMO

  • 15+ years of experience in product marketing in medical device industry.

Giri Devanur

  • Serial Entrepreneur 1 IPO and 3 Exits.
  • 27+ yrs. of technology industry experience.
  • MS, Columbia University.

Brett Felmey Vice President – Sales

  • 20+ years of experience in B2B sales with Fortune 500 companies.

Andy Bala

  • 20+ years of technology leadership experience with Johnson & Johnson.
  • MBA, M.Tech IIT-Madras.

Advisory Board

Surya Mohapatra

  • 35+ yrs of leadership experience in Healthcare Industry.
  • Former President & CEO of Quest Diagnostics.
  • Board Member of Xylem Inc, Leidos Inc, and Malaria No More.

Ben Baldanza

  • Former CEO of Spirit Airlines.
  • Board Member of JetBlue Airlines.
  • Operating Partner at Sterling Investments.

Kevin Quinn

  • Former Partner and Co-Head of Global Technology Banking at Goldman Sachs.
  • Chairman of NJEDA and Brady.